How big is the France Aesthetic Medicine Market?

The France Aesthetic Medicine Market size is expected to reach USD 506.86 million in 2024 and grow at a CAGR of 10.66% to reach USD 841.08 million by 2029. Read More

What is the current France Aesthetic Medicine Market size?

In 2024, the France Aesthetic Medicine Market size is expected to reach USD 506.86 million. Read More

Who are the key players in France Aesthetic Medicine Market?

AbbVie Inc. (AlLergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma and Johnson & Johnson are the major companies operating in the France Aesthetic Medicine Market. Read More

What years does this France Aesthetic Medicine Market cover, and what was the market size in 2023?

In 2023, the France Aesthetic Medicine Market size was estimated at USD 458.03 million. The report covers the France Aesthetic Medicine Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the France Aesthetic Medicine Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

France Aesthetic Medicine Market Share

Statistics for the 2023 & 2024 France Aesthetic Medicine market share, created by Mordor Intelligence™ Industry Reports. France Aesthetic Medicine share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of France Aesthetic Medicine Industry

The France aesthetic medicine market is moderate due to the presence of companies operating globally as well as regionally.

The competitive landscape includes an analysis of a few international as well as local companies which hold significant market shares and are well known including AbbVie Inc. (Allergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma, Sinclair Pharma PLC, and Johnson & Johnson, among others.